Vanguard Portfolio Management
CNTB

Vanguard Portfolio Management’s Connect Biopharma Holdings CNTB Stock Holding History

Vanguard Portfolio Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
+102,755
New +$249K ﹤0.01% 3106

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Vanguard Portfolio Management's CNTB Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 102,755 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #3106 among its holdings.

56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Vanguard Portfolio Management held 102,755 shares of Connect Biopharma Holdings worth $245K as of Q2 2026.
  • Connect Biopharma Holdings was a new Vanguard Portfolio Management position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3106 holding.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.